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Bacterial infections of the lower respiratory tract (e.g., pneumonia and 
pleuropneumonia) are common in adult horses, and one of the causes of pneumonia in 
horses is transport for long periods [61]. The clinical signs vary depending on the 
disease severity; the most common signs are fever, anorexia, cough, tachypnea, bilateral 
nasal discharge, and respiratory distress [68]. Bacterial pneumonia or pleuropneumonia 
occasionally leads to a critical illness, with mortality rates as high as 56% [65, 66, 74, 
75]. 
Various bacteria, including Gram-positive, Gram-negative, and anaerobic 
bacteria, can be isolated from respiratory tract specimens in affected horses, and mixed 
bacterial infection is commonly observed [74, 75]. The dominant pathogenic bacterium 
of pneumonia in adult horses is Streptococcus equi subsp. zooepidemicus [75], which is 
a beta-hemolytic Gram-positive Lancefield group C bacterium found in a wide range of 
species, including horses, pigs, monkeys, dogs, and humans [31, 64, 72, 79]. 
Streptococcus zooepidemicus is part of the normal bacterial microflora of the upper 
respiratory tract and caudal reproductive tract of horses [79], and is also an 
opportunistic pathogen associated with a wide variety of diseases in horses, including 
pneumonia, mastitis, placentitis, and endometritis [16, 39, 44, 52]. Previous studies 
have reported that S. zooepidemicus is not a homogeneous clonal population but 
consists of a wide diversity of strain types [7, 59], and furthermore that differences in 
genotype or phenotype of S. zooepidemicus might affect pathogenicity [45, 67]. 
Although S. zooepidemicus is a predominant pathogen in equine lower respiratory tract 
infection, microbial substitution occasionally occurs following the administration of 
antimicrobials. The other bacteria most frequently isolated before or after microbial 
substitution include Pasteurellaceae, Escherichia coli, Klebsiella spp., and obligate 
anaerobes [65, 75]. In particular, obligate anaerobes and E. coli tend to be responsible 
for secondary bacterial pneumonia [65]. The fatality rate from pleuropneumonia caused 
by these agents and secondary to bacterial pneumonia is high [65, 74]. 
Previous studies have reported that the major obligate anaerobes isolated from 
horses with signs of lower respiratory tract infection are Bacteroides spp. and 
Clostridium spp. [75]; anaerobic cocci and Eubacterium fossor [65]; and Clostridium 
perfringens, Bacteroides fragilis, and Bacteroides oralis [11]. Tracheobronchial 
aspirates were used mainly in these previous works. However, many other types of 
bacteria, including transient bacteria, were found at tracheal sites in another study [34]. 
In other studies, 69 of 148 healthy Thoroughbred horses had bacteria in their tracheas at 
concentrations of 1 to 104 CFU/ml [18] and the average concentration of bacteria in 
tracheal washes from Standardbred horses with no clinical signs was 1.49×104 CFU/ml 
[43]. It is unclear whether transient bacteria were included in the tracheobronchial 
aspirates in those previous studies that found obligate anaerobes. Therefore, accurate 
identification of obligate anaerobes is needed in lower respiratory tract infection in adult 
horses to select appropriate antimicrobials. 
Standard therapies for bacterial pneumonia or pleuropneumonia are 
administration of antimicrobial and nonsteroidal anti-inflammatory agents, and pleural 
drainage and lavage[68]. From an antimicrobial perspective it is reasonable to treat the 
disease -lactams such as penicillin or cephalosporin, because S. zooepidemicus, 
being considered the most likely causative pathogen in the early stages of 
bronchopneumonia in adult horses, is generally susceptible to -lactams [73]. In 
some cases, a combination of trimethoprim and sulfonamide, gentamicin, and 
fluoroquinolones such as enrofloxacin can be used for bronchopneumonia caused by 
aerobic or facultative anaerobic bacteria in adult horses [28, 51, 68]. Metronidazole is 
recommended for treatment of pneumonia caused by obligate anaerobes, because a 
-lactamases and are potentially resistant to 
-lactams [68]. However, the antimicrobial susceptibility patterns of each 
bacterium could vary depending on factors such as geographic location or time of year 
[5, 29, 40]. Veterinary practitioners should therefore consider suitable regimens based 
on the antimicrobial susceptibility patterns in each country or region. Moreover, because 
microbial substitution occasionally occurs following the administration of 
antimicrobials, it is important to determine the primary causative agents or microbial 
substitutions, or both, rapidly and to select the antimicrobials used accordingly to suit 
the causative bacteria and thus prevent progression of infection. 
Veterinary practitioners, however, are often faced with difficulties in 
conducting rapid diagnosis and choosing an appropriate antimicrobial. Isolating and 
identifying some bacteria such as obligate anaerobes is time consuming, and 
conventional polymerase chain reaction (PCR) assays, which can detect pathogens more 
quickly than can bacterial culture, need special equipment (e.g., a thermal cycler). 
Therefore, treatment of bacterial infections caused by obligate anaerobes is frequently 
empiric. 
The loop-mediated isothermal amplification (LAMP) method was developed as 
a new nucleic acid amplification method [60]. This method employs a DNA polymerase 
and a set of four specially designed primers that recognize a total of six distinct 
sequences on the target DNA [60]. The LAMP reaction can be accelerated by using 
additional primers, termed loop primers [55]. The mechanism of the LAMP reaction 
consists of three steps: production of starting material, cycling amplification, and 
recycling [60, 80]. The LAMP reaction can be performed under isothermal conditions 
with no special equipment, and its reaction temperature is between 60 and 65 °C the 
optimal temperature for Bst DNA polymerase. Various methods are available to detect 
products amplified by LAMP methods (e.g., the naked eye or use of a UV 
trans-illuminator, gel electrophoresis, and intercalating dyes [27, 60, 86]). It is generally 
considered that LAMP amplifies nucleic acids with high speed, specificity, and 
efficiency [27, 86]. In recent years, LAMP has been applied clinically for rapid 
detection of various pathogens [56, 58], and the LAMP method is potentially valuable 
as a diagnostic tool for rapid diagnosis of bacterial infections of the lower respiratory 
tract in affected horses in less well-equipped laboratories. 
The author conducted the following consecutive studies, the goal of which was 
to enable veterinary practitioners to identify causative bacteria promptly and to select 
appropriate antimicrobials. In CHAPTER 1, the author describes my use of 16S rRNA 
gene sequencing to precisely identify obligate anaerobes isolated from the lower 
respiratory tracts of ill horses. In CHAPTER 2, the author describes my development of 
five LAMP methods to detect major pathogens causing bacterial infections of the lower 
respiratory tract in Thoroughbred horses and compare the clinical efficacies of three 
simple DNA extraction methods. In addition, the author confirms the clinical efficacies 
of seven LAMP methods, namely the five new LAMPs and two previously described 
LAMPs. Last, in CHAPTER 3, the author reveals the antimicrobial susceptibility 
patterns of those pathogenic bacteria for which LAMP detection methods have been 
developed. 
CHAPTER 1 
Dominant obligate anaerobes revealed in lower respiratory tract infection 
in horses by 16S rRNA gene sequencing 
Summary 
Obligate anaerobes are important etiological agents in pneumonia or 
pleuropneumonia in horses, because they are isolated more commonly from ill horses 
that have died or been euthanized than from those that survive. The author performed 
bacterial identification for obligate anaerobes derived from ill horses with lower 
respiratory tract infection to reveal causative pathogens in Japan. The author used 16S 
rRNA gene sequencing to identify 58 obligate anaerobes and compared the results with 
those from a phenotypic identification kit. The identification results of 16S rRNA gene 
sequencing were more reliable than those of the commercial kit. The author concluded 
that genera Bacteroides and Prevotella especially B. fragilis and P. 
heparinolytica are dominant anaerobes in lower respiratory tract infection in horses. 
Introduction 
Obligate anaerobes are normal inhabitants of the oral cavity and intestinal tract 
of horses, but they are also sometimes isolated from horses with signs of respiratory 
infection or enteritis, or with abscesses or other lesions [11, 30, 41]. In particular, 
obligate anaerobes are secondary etiological agents in lower respiratory tract disease, 
and survival rates are significantly lower in horses from which obligate anaerobes are 
isolated than in horses from which anaerobes are not isolated [65, 74]. Because the 
pathogenicity or antimicrobial susceptibility patterns of bacteria vary depending on the 
species and genus [29, 70], accurate bacterial identification should be performed for 
selection of appropriate agents and assessment of clinical significance. 
Because not all veterinary bacteria are covered by commercial bacterial 
identification kits based on phenotypic methods, many veterinary isolates have not been 
correctly identified by these kits [25, 63]; such isolates are often identified instead by 
using 16S rRNA gene sequencing [14, 25]. 
My objective was to identify obligate anaerobes from horses with lower 
respiratory tract infection by using 16S rRNA gene sequencing and to compare the 
results with those of a commercial phenotypic identification kit. 
Materials and Methods 
Obligate anaerobes used in this study 
The 58 obligate anaerobes used in this study were isolated between 2001 and 
2010 from clinical specimens from 31 Thoroughbred horses with signs of lower 
respiratory tract infection. All specimens were incubated anaerobically on 5% horse 
blood agar at 37 °C for 48 hr. When a few kinds of obligate anaerobes were isolated 
from a single horse, one to four kinds of dominant isolates from each specimen were 
selected for the experiment. Thirty-six (62.1%) of the 58 isolates were obtained from 
bronchoalveolar lavage fluid (BALF), 13 (22.4%) were from pleural effusions and five 
(8.6%) from lung abscesses. The remaining four (6.9%) were isolated from horses with 
signs of pneumonia, but their origin was not recorded. 
Identification by 16S rRNA gene sequencing 
The 16S rRNA gene sequencing was performed in accordance with published 
methods [36, 37]. The sequences obtained were compared with published 16S rRNA 
gene sequences in the database of the National Center for Biotechnology Information by 
using BLAST software (http://blast.ncbi.nlm.nih.gov/) [4]. Sequence-based 
identifications were interpreted according to the criteria of the Clinical and Laboratory 
Standards Institute (CLSI), namely species level, 99.0% identity to the type strain; 
genus level, 97.0% to 99.0% identity to the type strain; novel genus or species, or both, 
<97.0% identity to the type strain [23]. In addition, because the CLSI guideline 
recommends constructing a phylogenetic tree for a strain that has identity of <97.0% to 
the type strain, the author used MEGA 5.03 software [77] to create a phylogenetic tree 
by using the neighbor-joining method with 1,000 bootstrap replicates. 
Identification by phenotypic method 
A commercial bacterial identification test kit (Rapid ID 32A, SYSMEX 
bioMérieux
to compare the identification results from 16S rRNA gene sequencing with those from 
the identification test kit. This kit uses, for species level, identification score (% id) 80 
and for genus level, % id of each bacterial species <80 and total % id of some bacterial 
species belonging to the same genus 80. 
Results 
Identification results of 16S rRNA gene sequencing 
Forty-four of 58 (75.9%) isolates were discriminated to genus level by 16S 
rRNA gene sequencing and phylogenetic analysis, and 37 of 58 (63.8%) isolates were 
identified to species level (Table 1-1). Although the isolates JAn-33 and JAn-35 to -39 
were not discriminated as members of the genus Prevotella according to the CLSI 
criteria (identity to the type strain <97.0%), according to the phylogenetic analysis, 
these six isolates belonged to a cluster of Prevotella (Fig. 1-1). The author therefore 
considered that the six isolates were strains related to Prevotella. Twenty-two of 58 
(37.9%) isolates belonged to the genus Bacteroides, and members of Bacteroides were 
the obligate anaerobes most commonly isolated. Of the Bacteroides, B. fragilis (15 
isolates) was the predominant species. Seventeen of 58 (29.3%) isolates belonged to the 
genus Prevotella, including the six related isolates. Members of Prevotella were the 
second most commonly isolated obligate anaerobes. Among members of Prevotella, P. 
heparinolytica (nine isolates) was the dominant species. Five of 58 (8.6%) isolates 
belonged to the genus Clostridium. As for the remaining 14 isolates, 16S rRNA gene 
sequences of seven, six and one isolates were the most similar to those of Eubacterium, 
Clostridium and Paraprevotella, respectively. However, the identities of the 14 isolates 
(91.2 95.2 ) were lower than the CLSI criteria (<97.0%). Unlike the strains related 
to Prevotella, the 14 strains did not belong to certain cluster according to the 
phylogenetic analysis (data not shown). Therefore, these 14 strains were not identifiable 
to genus level in terms of both identity to the type strain and the results of the 
phylogenetic analysis. 
Identification results of phenotypic method 
Rapid ID 32A identified 42 of 58 (72.4%) isolates to genus level and 29 of 58 
(50.0%) isolates to species level (Table 1-1). Thirty, seven and five of the 42 isolates 
were identified as genus Bacteroides, genus Clostridium and genus Prevotella, 
respectively. 
Comparison of two identification methods 
Twenty-two of 58 (37.9%) isolates had the same identification results to genus 
level by both identification methods, and 18 of 58 (31.0%) isolates had the same 
identification results to species level by the two methods. The identification results for 
the remaining 36 (62.1%) isolates differed between the two methods. In particular, all 
isolates identified as P. heparinolytica by 16S rRNA gene sequencing (JAn-23 to -31) 
were identified as strains associated with B. uniformis by Rapid ID 32A. 
Discussion 
As for bacterial identifications of obligate anaerobes, accordance rates between 
the result from 16S rRNA gene sequencing and those of phenotypic method are low in 
this study; 37.9% to genus level and 31.0% to species level. In agreement with my 
results, some identification kits have previously identified P. heparinolytica, including 
the type strain and clinical strains, as a strain associated with B. uniformis [3]. 
Phenotypic characterization by using identification test kits often results in unreliable 
identification, especially in the case of veterinary isolates [1, 14, 25, 63], and 16S rRNA 
gene sequencing has often provided reliable identifications of these otherwise 
unidentifiable strains [1, 14]. These findings combined indicate that 16S rRNA gene 
sequencing is a more reliable tool for identifying obligate anaerobes derived from 
horses than are kits based on phenotypic characterization. Hereafter, unless otherwise 
noted, the species names used here for isolates are those from the 16S rRNA gene 
sequencing. 
Previous studies have reported that the major obligate anaerobes obtained from 
horses with signs of lower respiratory tract infection are Bacteroides spp. and 
Clostridium spp. [74]; anaerobic cocci and Eubacterium fossor [65]; and Clostridium 
perfringens, Bacteroides fragilis, and Bacteroides oralis [11]. In agreement with my 
findings, these studies reported that strains of Bacteroides were among the dominant 
anaerobes in horses with signs of lower respiratory tract infection. However, in 
disagreement, they did not consider Prevotella a major causative anaerobe [11, 65, 74]. 
Tracheobronchial aspirates were used mainly in these previous works [11, 65, 74]. In 
contrast, the specimens the author used were predominantly BALFs, which are 
generally considered sterile in healthy horses. Unlike at bronchial sites, many bacteria, 
including transient bacteria, have been found at tracheal sites [34], suggesting that 
samples from bronchial sites are more suitable than those from tracheal sites for 
detecting causative or secondarily invasive obligate anaerobes. Therefore, the author 
concluded that my identification results would be more reliable than those of the 
above-mentioned past studies in terms of the sampling sites used. The author conclude 
that strains of Bacteroides and Prevotella in particular B. fragilis and P. 
heparinolytica are the most important obligate anaerobes in lower respiratory tract 
infection in horses. 
 To my knowledge, this is the first report to identify the obligate anaerobes in 
lower respiratory tract infections in horses by using 16S rRNA gene sequencing. The 
genera Bacteroides and Prevotella especially B. fragilis and P. heparinolytica were 
revealed to be the dominant obligate anaerobes. These reliable identifications should 
result in better choices of antimicrobials for treating anaerobic lower respiratory tract 
infections in horses. 

Fig. 1 1. 
Fig. 1 1. Neighbor-joining phylogenetic tree derived from 16S rRNA gene sequences, 
showing the positions of JAn-33 and -35 to -39 within the genus Prevotella. Accession 
numbers of published sequences of Prevotella species are shown in parentheses. 
Bootstrap values (>50%) based on 1,000 replications are shown at branch nodes. Bar, 
0.05 substitutions per nucleotide position. 
CHAPTER 2 
Development of loop-mediated isothermal amplification to detect seven groups of 
pathogens causing lower respiratory bacterial infection in horses and analysis of its use 
with three simple methods of extracting DNA from equine respiratory tract specimens 
Summary 
 Although Streptococcus equi subsp. zooepidemicus is a dominant pathogenic 
bacterium in equine lower respiratory tract infection, microbial substitution occasionally 
occurs following the administrations of antimicrobials. The author developed five 
specific loop-mediated isothermal amplification (LAMP) assays to detect equine 
respiratory pathogens, e.g., S. zooepidemicus, strains of the Bacteroides-Prevotella
group, Klebsiella pneumoniae, Stenotrophomonas maltophilia, and Staphylococcus 
aureus. The author examined the clinical efficacies of LAMP assay in combination with 
each of three DNA extraction methods easily used by veterinary practitioners, namely 
the Loopamp PURE DNA Extraction Kit, InstaGene Matrix, and a conventional boiling 
method. The LAMP method plus the Loopamp PURE DNA Extraction Kit gave higher 
rates of positivity than the other combinations in both clinical and spiked samples 
containing clinically significant concentrations (>1×104 CFU/ml) of S. zooepidemicus. 
The author then applied the five LAMP assays and two previously published LAMP 
assays targeting Escherichia coli or Pseudomonas aeruginosa to clinical respiratory 
specimens, showing high accordance rates between the results of LAMP assay and 
bacterial culture. Use of these LAMP assays could enable rapid detection of pathogenic 
bacteria and swift administration of the appropriate antimicrobials. 
Introduction 
Streptococcus equi subsp. zooepidemicus is a beta-hemolytic Gram-positive 
Lancefield group C bacterium found in a wide range of species, including horses, pigs, 
monkeys, dogs, and humans [31, 64, 72, 79]. It is part of the normal bacterial microflora 
of the upper respiratory tract and caudal reproductive tract of horses [79]. Streptococcus 
zooepidemicus is an opportunistic pathogen associated with a wide variety of diseases in 
horses, including pneumonia, mastitis, placentitis, and endometritis [16, 39, 44, 52]. In 
particular, S. zooepidemicus is a predominant pathogen in the bacterial pneumonia 
resulting from transport of horses for long periods [61]. Although S. zooepidemicus is a 
predominant pathogen in equine pneumonia, microbial substitution occasionally occurs 
following the administration of antimicrobials. In particular, obligate anaerobes and 
Escherichia coli tend to be the etiological agents of secondary bacterial pneumonia [65]. 
The fatality rate from pleuropneumonia caused by these agents and secondary to 
bacterial pneumonia is high [65, 74]. To prevent the progression of these infections it is 
important to diagnose causative pathogens and/or microbial substitutions rapidly and to 
select the antimicrobials used accordingly to suit the causative bacteria. 
Veterinary practitioners, however, are often faced with difficulties in 
conducting rapid diagnosis and choosing an appropriate antimicrobial. Isolating and 
identifying some bacteria such as obligate anaerobes is time consuming, and 
conventional polymerase chain reaction (PCR) assays, which can detect pathogens more 
quickly than bacterial culture, need special equipment such as thermal cycler. 
Loop-mediated isothermal amplification (LAMP) method was developed as a 
new type of nucleic acid amplification method [60]. LAMP amplifies nucleic acids with 
high speed, specificity, and efficiency, and it can be performed under isothermal 
conditions with no special equipment. In recent years, LAMP has been applied 
clinically as a method for rapid detection of various pathogens [33, 57]. Here, the author 
developed novel LAMP methods specific to the pathogenic bacteria found in equine 
lower respiratory tract infection, namely, S. zooepidemicus, the Bacteroides-Prevotella
group, Klebsiella pneumoniae, Stenotrophomonas maltophilia, and Staphylococcus 
aureus. The author then applied these five newly developed LAMP assays and two 
previously described ones targeting Escherichia coli [35] and Pseudomonas aeruginosa
[32] to clinical samples to assess the efficacy of the assays in diagnosing lower 
respiratory tract infection in horses. 
The process of DNA extraction from clinical samples is necessary for various 
genetic tests, including LAMP. However, veterinary practitioners are unable to use most 
DNA extraction methods, because they require complicated processes that are 
time-consuming and labor-intensive. Here, the author also compared the results 
obtained when LAMP was used with each of three DNA extraction methods that 
veterinary practitioners could apply easily to clinical samples. 
Materials and Methods 
Primer designs 
All LAMP primers were designed by using PrimerExplorer V4 software 
(Fujitsu Limited, Tokyo, Japan). The primer sets included five or six primers: two outer 
primers (F3 and B3), two inner primers (FIP and BIP), and one or two loop primer 
(Loop B, or Loop B and Loop F), and the primer sequences for the LAMP methods are 
shown in Table 2-1. Primers for species-specific LAMPs to detect S. zooepidemicus
(Sz-LAMP), K. pneumoniae (Kp-LAMP), S. maltophilia (Sm-LAMP), and S. aureus
(Sa-LAMP) were designed on the basis of published sequences of sorD, tyrosine 
aminotransferase, smeT, and nuclease gene, respectively. The GenBank accession 
numbers were showed in Table 2-2. The LAMP primers for detecting obligate anaerobes 
were focused on Bacteroides spp. and Prevotella spp. (Bac-Pre-LAMP); these species 
were revealed to be dominant obligate anaerobes in equine respiratory tract infection in 
CHAPTER 1. To select the specific region of the 16S rRNA gene for the 
Bacteroides-Prevotella group, the author compared the 16S rRNA gene sequences of 58 
obligate anaerobes previously isolated from the equine respiratory tract in CHAPTER 1 
and 24 gene sequences of various bacteria registered in GenBank (Table 2-2). These 
16S rRNA gene sequences were also used to create a phylogenetic tree by using the 
neighbor-joining method with 1,000 bootstrap replicates using MEGA 5.03 software 
[77]. 
LAMP methods 
The reaction mixture was prepared by using a Loopamp DNA Amplification 
, or Loop B and Loop F
Bst , The seven LAMP assays 
(the five new developed assays and the two previously described assays targeting E. coli
(Ec-LAMP) [35] and P. aeruginosa (Pa-LAMP) [32]) were separately performed at 
65 °C for 60 min and then terminated by heating the mixtures at 80 °C for 5 min. LAMP 
products were detected by monitoring the turbidity with a real-time turbidimeter 
(LA-320C, Eiken Chemical Co., Ltd.). 
Specificities 
 To confirm the specificities of the Sz-LAMP, the author examined 172 strains, 
all of which except for a type strain of S. zooepidemicus (ATCC 43079T) were isolated 
from diseased horses between 1980 and 2013. The 172 strains comprised 51 strains of S. 
zooepidemicus, 50 strains of Streptococcus equi subsp. equi, 23 strains of Streptococcus 
dysgalactiae subsp. equisimilis, 18 strains of other Streptococcus species including 
Streptococcus pneumonia, which is generally human pathogenic bacterium, and 30 
strains belonging to other genera frequently isolated from horses (Table 2-3). The author 
examined 115 bacterial strains to confirm the specificity of the Bac-Pre-LAMP. The 115 
strains comprised 58 obligate anaerobes isolated from the respiratory tracts of horses in 
CHAPTER 1, 12 reference strains purchased from the American Type Culture 
Collection (ATCC) and 45 strains belonging to other genera frequently isolated from 
horses (Table 2-4). The author used 185 bacterial strains to examine specificities for 
Kp-LAMP (Tables 2-5), 82 strains for Sm-LAMP (Tables 2-6), and 168 strains for 
Sa-LAMP (Tables 2-7). Each bacterial DNA was extracted from fresh bacterial culture 
by using InstaGene Matrix (Bio-Rad Laboratories, Tokyo, Japan) in accordance with the 
Detection limits of each LAMP assays 
To measure the detection limits of the seven LAMP assays, 10-fold serial 
dilutions of a suspension of each bacterium were prepared, and the colony forming units 
(CFUs) in the suspensions were counted: Bacteroides fragilis ATCC 25285T was used as 
a representative obligate anaerobe because B. fragilis is a dominant target of 
Bac-Pre-LAMP. In the case of the other six LAMP assays (Sz-, Kp-, Sm-, Sa-, Ec-, and 
Pa-LAMPs), the author used the respective type strains, namely S.zooepidemicus ATCC 
43079T, K. pneumoniae ATCC 13883T, S. maltophilia ATCC 13637T, S. aureus ATCC 
12600T, E. coli ATCC 11775T, and P. aeruginosa ATCC 10145T. Bacterial DNA in the 
suspensions was then extracted by using a Loopamp PURE DNA Extraction Kit (Eiken 
Chemical Co., Ltd.) in accordance 
were performed three times for each LAMP method; the lowest bacterial concentrations 
that yielded positive results at least twice were regarded as the detection limits 
(CFU/ml). 
Three different DNA extraction methods for applying to clinical samples 
Three DNA extraction methods were selected, namely a Loopamp PURE DNA 
Extraction Kit, InstaGene Matrix or a boiling method, because they could be performed 
with only a few steps and within 30 min. The Loopamp PURE DNA Extraction Kit and 
InstaGene Matrix were used 
the boiling method, samples were boiled at 100 °C for 10 min and were centrifuged at 
13,000 g for 3 min. The aliquots obtained from the supernatant were then subjected to 
LAMP analysis. 
Comparison of efficacies of three different DNA extraction methods 
To measure the detection limits of the LAMP method in combination with each 
of three different DNA extraction methods, 10-fold serial dilutions of a suspension of S. 
zooepidemicus were prepared, and the colony forming units (CFUs) in the suspension 
were counted. Bacterial DNA in the suspensions was then extracted by using one of the 
three DNA extraction methods. Sensitivity tests were performed three times for each 
DNA extraction method. 
Fifty-four clinical samples and 34 spiked samples which were prepared 
experimentally were used in this study to compare the efficacies of the three DNA 
extraction methods. Of the 54 clinical samples obtained from the respiratory tracts of 
Thoroughbred horses, one was obtained in 2010, 25 in 2012, and 28 in 2013. The 54 
clinical samples consisted of 33 bronchoalveolar lavage (BAL) fluids, 12 tracheal 
washes, 8 pleural effusions, and one guttural pouch lavage specimen. The clinical 
samples were suspended in equal amount of Cary-Blair medium and were transported to 
my  of the mixtures were incubated aerobically on 5% horse 
blood agar at 37 °C for 24 hr. The remaining samples were stored at 20 °C until DNA 
isolation. Thirty-four of 54 clinical samples yielded S. zooepidemicus at less than 20 
CFU/ml, which is detection limit in this study. The concentration of S. zooepidemicus
was between 20 CFU/ml and 1×104 CFU/ml in 6 of 54 samples and greater than 1×104
CFU/ml in 14 of 54 samples. To prepare the spiked samples, 34 clinical samples with S. 
zooepidemicus concentrations of less than 20 CFU/ml were spiked at one-tenth their 
volumes with a suspension in which the concentration of S. zooepidemicus (ATCC 
43079T) was 1×107 CFU/ml. The final concentration of S. zooepidemicus in each spiked 
sample was at least 1×106 CFU/ml. Bacterial DNA in the 54 clinical samples or 34 
spiked samples was extracted by using one of the three DNA extraction methods, and 
then each DNA was applied to Sz-LAMP. 
Application for clinical and spiked samples 
The author used 67 clinical samples to assess the clinical efficacies of the seven 
LAMP assays. The 67 clinical samples comprised 54 samples described above and 
additional 13 samples collected in 2013 to 2014. The 67 clinical samples consisted of 41 
bronchoalveolar lavage fluids (BALFs), 14 tracheal washes, 11 pleural effusions, and 
one guttural pouch lavage fluid. Clinical samples were prepared in the same manner as 
described above. The author 
on 5% horse blood agar and MacConkey agar for 24 hr and anaerobically on 5% horse 
blood agar for 48 hr. Bacteria were identified by using Gram staining and a commercial 
identification kit (API Systems, SYSMEX bioMérieux, Tokyo, Japan). The remaining 
samples were stored at 20 °C until DNA isolation.
Bacterial DNA was extracted from clinical samples by using a Loopamp PURE 
DNA Extraction Kit. The extracted DNA was then used in each LAMP assay. To 
confirm the clinical specificity of each LAMP method, specific PCRs that separately 
detect the Bacteroides fragilis group and Prevotella group [50], E. coli [10], K. 
pneumoniae [46] and S. maltophilia [84] were used on the clinical samples that gave 
positive results in each LAMP assay. The rates of accordance between the results of 
bacterial culture and those of the LAMP assays were calculated separately on the basis 
of the clinically important bacterial culture value (accordance rate 1: 1×104 CFU/ml) 
and the detection limit of bacterial culture (accordance rate 2: 20 CFU/ml), as below: 
Accordance rate 1 (%) = 100 × (numbers of samples with both 1×104 CFU/ml and 
LAMP positive + numbers of samples with both <1×104 CFU/ml and LAMP negative) / 
(total numbers of clinical samples), Accordance rate 2 (%) = 100 × (numbers of samples 
with both 20 CFU/ml and LAMP positive + numbers of samples with both <20 
CFU/ml and LAMP negative) / (total numbers of clinical samples). 
Results 
Phylogenetic tree 
According to the phylogenetic tree derived from 16S rRNA gene sequences of 
various bacteria (Figure 2-1), the strains of Bacteroides and Prevotella dominant 
obligate anaerobes associated with respiratory disease in horses  formed a 
Bacteroides-Prevotella-Porphyromonas group and were obviously separated from the 
aerobes, facultative anaerobes and obligate anaerobes except for 
Bacteroides-Prevotella-Porphyromonas group. 
Specificities 
Amplification in the Sz-, Bac-Pre-, Kp-, Sm-, and Sa-LAMPs was confirmed 
for all strains of S. zooepidemicus, Bacteroides and Prevotella, K. pneumoniae, S. 
maltophilia, and S. aureus, respectively. No amplification of DNA from non-target 
bacteria by the five LAMP products was confirmed except for strains of Porphyromonas
in the Bac-Pre-LAMP. 
Efficacies of three different DNA extraction methods 
The detection limits of the Sz-LAMP in combination with the Loopamp PURE 
DNA Extraction Kit, InstaGene Matrix, and boiling method for pure culture were 1×105, 
1×103, and 1×104 CFU/ml, respectively. These detection limits (CFU/ml) of the LAMP 
with the Loopamp PURE DNA Extraction Kit, InstaGene Matrix, and boiling method 
are equal to 200 CFU/reaction, 2 CFU/reaction, and 20 CFU/reaction, respectively. 
Thirteen of 14 clinical samples with S. zooepidemicus concentrations greater 
than 1×104 CFU/ml were positive by the LAMP method plus the Loopamp PURE DNA 
Extraction Kit; 11 of these 14 clinical samples were positive with LAMP plus InstaGene 
Matrix, and 7 were positive with LAMP plus boiling (Table 2-8). Thirty-four of 34 
spiked samples were positive with LAMP plus the Loopamp PURE DNA Extraction 
Kit; 31 were positive with LAMP plus InstaGene Matrix and 27 with LAMP plus 
boiling. Among the 40 clinical samples in which S. zooepidemicus concentrations were 
either less than 20 CFU/ml or 20 to 1×104 CFU/ml, one clinical sample was positive 
with LAMP plus the Loopamp PURE DNA Extraction Kit, two with LAMP plus 
InstaGene Matrix, and one with LAMP plus boiling. 
Detection limits 
The detection limits of Sz-, Bac-Pre-, Sa-, and Pa-LAMPs in combination with 
the Loopamp PURE DNA Extraction Kit were 1×105 CFU/ml and those of Kp-, Sm-, 
and Ec-LAMPs were 1×104 CFU/ml. The detection limits of 1×104 CFU/ml and 1×105
CFU/ml were equal to 20 CFU/reaction and 200 CFU/reaction, respectively, in the 
LAMP assays. 
Application for clinical samples 
Of the 67 clinical samples, 36 gave positive results in at least one LAMP assay 
(Table 2-9): 19 samples were positive on Sz-LAMP, 19 on Bac-Pre-LAMP, four on 
Ec-LAMP, four on Kp-LAMP and two on Sm-LAMP (Table 2-10). Thirty-two of 36 
clinical samples (88.9%) with >1×104 CFU/ml of the target bacterium were positive in 
the relevant LAMP assays. The four samples (J13-15, J13-20, J13-31, and J13-35), with 
4 CFU/ml of target bacterium and relevant LAMP negative, contained 
2.4×104 CFU/ml to 8.6×104 CFU/ml of S. zooepidemicus or S. aureus slightly lower 
than the detection limit of Sz- and Sa-LAMP (1×105 CFU/ml). Except for S. 
zooepidemicus of which specific PCR for detection has not been reported available for 
clinical sample, all clinical samples that were LAMP positive in some of which the 
bacterial concentrations were less than the detection limits of the LAMP assays were 
also positive by each group- or species-specific PCR reaction. The overall accordance 
rates of the Sz-LAMP and Bac-Pre-LAMP results with the results of bacterial culture 
were both 91.0%, using a threshold bacterial concentration of 1×104 CFU/ml, and 
85.1% and 88.1%, respectively, using a threshold of 20 CFU/ml (Table 2-10). The 
accordance rates of the other five LAMP assays were 94.0% to 100% (using 1×104
CFU/ml) and 95.5% to 100% (using 20 CFU/ml). 
Discussion 
Multiplex PCR [2] and multiplex real-time PCR [9] for detecting S. 
zooepidemicus and S. equi, have been described previously. These two published 
PCR-based methods use two genes: sodA, which encodes a manganese-dependent 
superoxide dismutase, for detecting both S. zooepidemicus and S. equi; and seeI, which 
encodes pyrogenic mitogen SePE-I, for detecting only S. equi. The two methods cannot 
judge the presence or absence of S. zooepidemicus when a sample contains S. equi, 
because they do not use a primer set that can detect only S. zooepidemicus. Therefore, 
the two methods are appropriate for identifying each species in pure culture, but are not 
suitable for detecting S. zooepidemicus in clinical samples. Carbohydrate (e.g. lactose, 
sorbitol, and trehalose) fermentation testing is commonly used to differentiate between 
S. zooepidemicus and S. equi [6]. All S. equi strains lack the sorD gene that encodes 
sorbitol-6-phosphate 2-dehydrogenase and therefore lack the ability to ferment sorbitol, 
whereas all S. zooepidemicus strains possess sorD [38]. This genetic basis indicates that 
sorD should be suitable for differentiating S. zooepidemicus from S. equi and, as a result, 
the Sz-LAMP targeting the sorD gene could specifically detect S. zooepidemicus in this 
study. 
In the study described in CHAPTER 1, strains belonging to the 
Bacteroides-Prevotella cluster accounted for 67.2% (39 of 58 strains) of pathogenic 
obligate anaerobes in the equine respiratory tract infection; these bacteria were found in 
93.5% (29 of 31 horses) of horses that were sick with lower respiratory tract infection 
involving with obligate anaerobes (data not shown). Although the author did not isolate 
Porphyromonas spp., which Bac-Pre-LAMP could detect, Porphyromonas is one of the 
pathogens causing equine pneumonia [65]. Bac-Pre LAMP, therefore, could broadly 
detect pathogenic obligate anaerobes in lower respiratory tract specimens from horses. 
Collectively, the high specificities of the five new developed LAMP assays were 
confirmed. 
In a previous study, 69 of 148 healthy Thoroughbred horses had bacteria in 
their tracheas at concentrations of 1 to 104 CFU/ml; the concentration of the bacteria 
was greater than 1×104 CFU/ml in only seven of these horses [18]. In another previous 
study, the average concentration of bacteria in tracheal washes from Standardbred 
horses with no clinical signs was 1.49×104 CFU/ml [43]. Moreover, the presence of 
bacteria at concentrations greater than 1×104 CFU/ml in human BAL samples is 
associated with clinical disease [8]. The author therefore considered a concentration of 
greater than 1×104 CFU/ml in clinical samples to be of clinical importance. Thus, the 
author divided the clinical samples into three groups by using two thresholds: 20 
CFU/ml (the detection limit of my bacterial culture) and 1×104 CFU/ml. 
The clinical efficacy of a genetic test can sometimes differ from the results of 
sensitivity testing in in vitro experiments using pure bacterial culture [53, 54], because 
each DNA extraction method has a different performance in terms of DNA purification 
or the yield of DNA extracted from clinical specimens. Therefore, the author used 
clinical samples and spiked samples to assess the clinical efficacies of three DNA 
extraction methods; Loopamp PURE DNA Extraction Kit, InstaGene Matrix, and 
boiling. Although the sensitivity of the LAMP method plus the Loopamp PURE DNA 
Extraction Kit was 10 to 100 times lower than those with InstaGene Matrix or boiling, 
the combination of LAMP plus the Loopamp PURE DNA Extraction Kit could detect S. 
zooepidemicus in both clinical and spiked samples more efficiently than the other 
methods. Because the bacterial concentrations in the spiked samples were sufficient to 
give positive results by the Sz-LAMP in pure culture, the LAMP method would 
theoretically be expected to give positive results in all spiked samples. However, not all 
spiked samples were positive by LAMP plus InstaGene Matrix or the boiling method; 
100% detection was obtained only with the Loopamp PURE DNA Extraction Kit. Many 
inhibitors are present in specimens from the respiratory tract, and they can cause 
false-negative results in PCR [42, 85]. These inhibitory substances either bind to 
ymerase or both, during primer 
extension [62, 85]. The inhibitors remaining after DNA extraction using InstaGene 
Matrix or boiling might inhibit the LAMP reaction; using the Loopamp PURE DNA 
Extraction Kit would be more likely to reduce the effect of these inhibitors than would 
the other extraction methods. My results suggest that the InstaGene Matrix and boiling 
methods are unsuitable for use on clinical samples because they can yield false 
negatives; the LAMP method plus the Loopamp PURE DNA Extraction Kit is the most 
appropriate for use on clinical samples. LAMP plus the Loopamp PURE DNA 
Extraction Kit gave a positive result in one clinical sample in which the S. 
zooepidemicus concentration was less than 20 CFU/ml, despite the fact that the 
detection limit of this combination in pure culture was 1×105 CFU/ml. This 
inconsistency may have been caused by the presence of dead S. zooepidemicus in the 
sample, because the samples were collected after the administration of antimicrobials. 
The seven LAMP methods in combination with the Loopamp PURE DNA 
Extraction Kit obtained high accordance rates with bacterial culture. These high 
accordance rates indicate that LAMP assays could be useful tools for detecting the 
bacterial pathogens causing lower respiratory tract infection in horses. 
In conclusion, the author developed LAMP methods for detecting S. 
zooepidemicus, strains of the Bacteroides-Prevotella group, K. pneumoniae, S. 
maltophilia and S. aureus. These methods can yield results within 1 hr, and unlike 
previous PCR-based methods, it can be applied to clinical samples without the need for 
special equipment. The seven LAMP assays, the five new LAMP assays and two 
previously published LAMP assays targeting Escherichia coli or Pseudomonas 
aeruginosa, could be conducted simultaneously at the same temperature (65 °C). The 
LAMP method in combination with the Loopamp PURE DNA Extraction Kit is 
efficient for clinical and spiked samples containing clinically significant concentrations, 
and it takes a total of only about 90 min from receiving the specimens to obtaining the 
LAMP results. In this way, the author can concurrently perform LAMP assays to detect 
both the primary and secondary causative pathogens of lower respiratory bacterial 
infections in adult horses within only 90 min with the naked eye; consequently, it will 
be possible to institute appropriate antimicrobial therapies more quickly in horses with 












Fig. 2 1 
Fig. 2 1. Neighbor-joining phylogenetic tree derived from 16S rRNA gene sequences, 
showing the separation of Bacteroides and Prevotella from other obligate anaerobes, as 
well as from aerobes and facultative anaerobes. Accession numbers of published 
sequences are shown in parentheses. Bootstrap values (>50%) based on 1,000 
replications are shown at branch nodes.  
CHAPTER 3 
Antimicrobial susceptibility patterns of dominant pathogenic bacteria from 
equine respiratory tract of ill horses 
Summary 
 For appropriate antimicrobial use, veterinary practitioners should select 
antimicrobials on the basis of evidence, namely isolation frequencies of each pathogenic 
bacterium and antimicrobial susceptibility patterns. In this study, the author revealed 
antimicrobial susceptibility patterns of representative causative bacteria of respiratory 
tract in adult horses; Streptococcus equi subsp. zooepidemicus, obligate anaebores, 
Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Stenotrophomonas 
maltophilia, and Staphylococcus aureus. 22 antimicrobials were examined for their 
susceptibilities against facultative anaerobic and aerobic bacteria, and 11 antimicrobials 
were examined against obligate anaerobes. The results showed all of S. zooepidemicus
isolates were susceptible to all - -lactams are first-line drug for 
bacterial infections in lower respiratory tract in adult horses. On the other hands, S. 
zooepidemicus and E. coli showed an increase in percent of isolates resistant to 
tetracycline and minocycline, in particular, minocycline-resistant S. zooepidemicus has 
significantly increased in 2010-2014. As for obligate anaerobes, all Bacteroides and 
Prevotella isolates were susceptible to imipenem, clindamycin, and metronidazole. 
These antimicrobial susceptibility patterns could be efficient evidence; veterinary 
practitioners could select appropriate antimicrobials for bacterial infections in lower 
respiratory tract in adult horses immediately after causative bacteria are revealed by 
using the LAMP methods described in CHAPTER 2. 
Introduction 
 Antimicrobial use is one of the essential therapies to treat with bacterial 
infection in lower respiratory tract in horses, and veterinary practitioners have used 
various antimicrobials for those horses [28, 68]. Inappropriate antimicrobial therapies, 
e.g., usage against antimicrobial resistant pathogens, or improper dosage or interval, are 
associated with increased morbidity and fatality [26]. Therefore, veterinary practitioners 
should select appropriate antimicrobials on the basis of evidence, namely isolation 
frequencies of each pathogenic bacterium and its antimicrobial susceptibility patterns. 
Antimicrobial susceptibility tests of each bacterium should be ideally conducted in each 
clinical case. However, most veterinary practitioners are faced with difficulties to reveal 
antimicrobial susceptibility of the pathogens in each clinical case, because there are 
many limitations; e.g., no facilities for conducting susceptibility tests, short-handed, and 
costs. Moreover, even if veterinary practitioners proceed with an order of susceptibility 
tests, they should select antimicrobials empirically until results of susceptibility tests are 
revealed. Thus, many veterinary practitioners rely on antimicrobial susceptibility 
patterns of past strains. Antimicrobial susceptibility patterns of bacteria vary depending 
on the species or genus [70], geographic location, and hospital-specific factors [40, 78]. 
Therefore, veterinary practitioners should acquire antimicrobial susceptibility patterns 
which are constructed by accumulating the patterns of each regional bacterium. 
In this CHAPTER, the author revealed antimicrobial susceptibility patterns of 
the pathogenic bacteria which cause bacterial infection in lower respiratory tract in 
horses and were also targeted of the LAMP methods in CHAPTER 2; i.e., S. 
zooepidemicus, obligate anaerobes, E. coli, P. aeruginosa, K. pneumoniae, S. 
maltophilia, and S. aureus. Combination of the results of the LAMP assays described in 
CHAPTER 2 and the susceptibility patterns revealed in this chapter could enable 
veterinary practitioners to select appropriate antimicrobials rationally on the basis of 
evidence. 
Materials and Methods 
Bacteria used in this study 
 All bacterial isolates were collected from ill horses with respiratory tract 
infections in this study. Primary isolated strain was used if same bacterial species were 
isolated from several specimens of a single horse. Detailed information of bacterial 
isolates used in this study is shown in Table 3-1. 
Antimicrobial susceptibility test 
The author measured the minimum inhibitory concentrations (MICs) of 
antimicrobials by using customized commercial panels (Eiken Chemical Co., Ltd., 
Tokyo, Japan). The MIC50 was the concentration of drug required to inhibit the growth 
of 50% of the isolates tested, and the MIC90 was the concentration required to inhibit 
90% of them. The panels for all strains except for obligate anaerobes include 22 
antimicrobials, namely, penicillin, ampicillin, cephalothin, ceftiofur, ceftriaxone, 
imipenem, enrofloxacin, marbofloxacin, levofloxacin, garenoxacin, vancomycin, 
sulfamethoxazole/trimetoprim, tetracycline, minocycline, tobramycin, amikacin, 
gentamicin, kanamycin, rifampicin, fosfomycin, chloramphenicol, and azithromycin. 
The panel for obligate anaerobes includes nine antimicrobials; penicillin, ampicillin, 
cephalothin, imipenem, clindamycin, metronidazole, minocycline, doxycycline, and 
moxifloxacin. The results were interpreted according to CLSI guidelines [21, 22, 24] 
and the author used Bacteroides fragilis ATCC 25285, Bacteroides thetaiotaomicron
ATCC 29741, and Staphylococcus aureus ATCC 29213 as quality control strains. MICs 
of the antimicrobial agents for these three strains were within the quality control limits 
described in CLSI standard M100-S22 [24]. 
Statistics 
as conducted for statistical analysis of comparisons 
between years for each resistant rate. A P-
significant difference in this study. 
Results 
Antimicrobial susceptibility patterns of the five facultative anaerobic and one 
aerobic bacteria are shown in Table 3-2. All isolates of S. zooepidemicus were 
-lactams, levofloxacin, and sulfamethoxazole/trimethoprim in this study. 
On the other hands, all of S. zooepidemicus were resistant to aminoglycosides such as 
amikacin, gentamicin, and kanamycin. S. zooepidemicus showed an increase in percent 
of isolates resistant to tetracycline and minocycline, in particular, minocycline-resistant 
S. zooepidemicus significantly increased in 2010-2014 (Table 3-3). Similarly, E. coli
showed an increase in percent of isolates resistant to tetracycline and minocycline. 
However, all of E. coli were susceptible to ceftriaxone, imipenem, and fosfomycin, and 
91.7% to 95.8% of the isolates were susceptible to aminoglycosides and levofloxacin. 
As for P. aeruginosa, all of the isolates were susceptible to imipenem, levofloxacin, and 
amikacin. Except for amikacin, 24.1% to 96.6% of P. aeruginosa were resistant to 
aminoglycosides. Unlike S. zooepidemicus, 12 of 13 S. maltophilia isolates were 
resistant to sulfamethoxazole/trimethoprim in this study. All of the isolates were 
susceptible to levofloxacin and minocycline, and 76.9% to 100% of S. maltophilia were 
resistant to aminoglycosides. No isolates of K. pneumonia and S. aureus were resistant 
to the cephalosporins, and all of both species were susceptible to levofloxacin, 
sulfamethoxazole/trimethoprim, minocycline, and amikacin. Five of six S. aureus
isolates were resistant to gentamicin and kanamycin. 
As for obligate anaerobes, Bacteroides isolates tended to be resistant to most of 
-lactam antimicrobials, including penicillin, ampicillin, cephalothin (Table 3-4). In 
contrast, approximately 80% of Prevotella isolates were susceptible to these 
antimicrobials. All Bacteroides and Prevotella isolates were susceptible to imipenem, 
clindamycin and metronidazole. 
Discussion 
In Japan, clinically ill adult horses with bacterial infection in lower respiratory 
tract have been generally administered penicillins or cephalosporins as first-line drug, 
e.g., penicillin, cephalothin, cefazolin, because S. zooepidemicus which is primary 
causative pathogen -lactams [68]. 
Although a few S. zooepidemicus isolates which were -lactams were 
reported in equine medicine in USA and UK [29, 40], all S. zooepidemicus isolates used 
in this study were -lactams. Therefore, penicillins and cephalosporins 
are still useful as first-line drug for bacterial infection in lower respiratory tract in adult 
horses in Japan. -lactams and aminoglycosides are usually used for 
bacterial infection in lower respiratory tract in equine medicine because the combination 
can cover broad range of bacteria; Gram positive bacteria tend to be susceptible to 
-lactams and Gram negative bacteria tend to be susceptible to aminoglycoside [28, 68]. 
Moreover, the combination was reported to have synergy effects to some bacteria in 
human medicine [47, 83]. Although 55% to 87.5% of S. zooepidemicus and 89% to 
100% of S. aureus isolates were reported to be gentamicin-susceptible in some previous 
papers [20, 29, 73], all S. zooepidemicus and five of six S. aureus isolates were resistant 
to gentamicin and kanamycin in this study. Clinical efficacy of the combination of 
-lactams and aminoglycosides for the resistant strains is unclear, even though synergy 
effects might exist. Levofloxacin showed good efficacies in in vitro experiments for 
facultative anaerobic and aerobic bacteria in this study. Moreover, new fluoroquinolones, 
unlike aminoglycosides, retain high activity in acid environment and in abscess cavity 
[13, 82]. Therefore, the combinations of -lactams and new fluoroquinolones might be 
more effective -lactams and aminoglycosides to treat the mixed 
infections caused by Gram-positive and Gram-negative bacteria. 
Although Sulfamethoxazole/trimethoprim is used for bacterial infection in 
lower respiratory tract in foreign equine medicine [17, 51, 81], only 30.9% to 63% of S. 
zooepidemicus isolates were susceptible to sulfamethoxazole/trimethoprim in some 
country [20, 29, 73]. However, because all S. zooepidemicus isolates were susceptible to 
sulfamethoxazole/trimethoprim in this study, sulfamethoxazole/trimethoprim might be 
effective to treat with a bacterial infection in lower respiratory tract in Japan. 
Sulfamethoxazole/trimethoprim is also used for some pathogens such as pneumocystis 
pneumonia [71] or S. maltophilia infection in human medicine [19]. Unlike S. 
zooepidemicus, 12 of 13 S. maltophilia isolates were resistant to 
sulfamethoxazole/trimethoprim in this study and thus, sulfamethoxazole/trimethoprim 
could not be recommended to treat with the lower respiratory tract infections caused by
S. maltophilis in equine medicine in Japan. 
In addition to -lactams, minocycline is frequently added for severe bacterial 
pneumonia or pleuropneumonia in equine medicine in Japan. However, because S. 
zooepidemicus and E. coli showed an increase in percent of isolates resistant to 
minocycline, veterinary practitioners should conduct antimicrobial susceptibility test 
and confirm the bacterial susceptibility to minocycline before the agent would be used. 
In agreement with previous studies in human medicine [49, 69], most of my 
Bacteroides isolates were resistant to most -lactams. In contrast, approximately 80% of 
Prevotella -lactams, although previous studies have 
reported that many Prevotella isolates in human medicine are resistant to penicillin [12, 
49, 69] -lactams may be effective against equine respiratory tract infections 
caused by Prevotella strains. Although metronidazole has been regarded as a useful 
antimicrobial for the treatment of obligate anaerobes in equine medicine [15, 48, 76], 
metronidazole-resistant Bacteroides and Prevotella strains have recently been reported 
in humans [70]. All of my Bacteroides and Prevotella isolates were susceptible to 
metronidazole, suggesting that this drug may still be useful against obligate anaerobes 
in horses. 
Administration of antimicrobials is one of the standard therapies for bacterial 
pneumonia or pleuropneumonia in horses [68]. Veterinarians should empirically select 
antimicrobials on the basis of evidence; e.g., isolation frequencies of each causative 
bacterium and antimicrobial susceptibility patterns. Antimicrobial susceptibility patterns 
of bacteria vary depending on the species or genus [70], geographic location, and 
hospital-specific factors [40, 78]. Therefore, antimicrobial susceptibilities revealed in 
this chapter could be very useful information for bacterial infection in lower respiratory 
tract in horses in Japan. Furthermore, veterinarians can promptly decide reasonable 
selection of antimicrobials by using both LAMP methods described in CHAPTER 2 and 
the antimicrobial susceptibility patterns. The author considers that these quick 
identifications of causative pathogens and appropriate selection of antimicrobials lead to 









In this thesis, the author have described studies relating to bacterial infection of 
the lower respiratory tract in adult horses with the aim of enabling veterinary 
practitioners to diagnose the causative bacteria promptly and to select appropriate 
antimicrobials. 
 In CHAPTER 1, the author described the use of 16S rRNA gene sequencing for 
precise species-level identification of obligate anaerobes isolated from the lower 
respiratory tract of ill horses, with the aim of revealing the causative obligate anaerobes. 
The obligate anaerobes that the author isolated most commonly from horses with signs 
of lower respiratory tract infection were Bacteroides spp. (22 of 58 isolates; 37.9%) in 
particular B. fragilis (15 isolates). The second most commonly isolated obligate 
anaerobes were Prevotella spp. (17 of 58 isolates; 29.3%) in particular P. 
heparinolytica (nine isolates). Isolates belonging to either Bacteroides or Prevotella
were found in 93.8% (30 of 32 horses) of horses that were sick with lower respiratory 
tract infection involving obligate anaerobes. The results indicated that strains of 
Bacteroides and Prevotella were the most important obligate anaerobes in lower 
respiratory tract infection in adult horses. 
 In CHAPTER 2, the author described my development of five LAMP methods 
to detect bacteria causing lower respiratory tract infection in horses, namely S. equi
subsp. zooepidemicus, strains of the Bacteroides-Prevotella group, K. pneumoniae, S. 
maltophilia, and S. aureus. Four of the newly developed LAMPs (Sz-, Kp-, Sm-, and 
Sa-LAMPs) were confirmed to be species-specific, whereas Bac-Pre-LAMP was 
verified to broadly detect bacteria of the Bacteroides-Prevotella-Porphyromonas group, 
which were dominant obligate anaerobes in lower respiratory tract specimens from 
horses. The author then compared the clinical efficacies of three DNA extraction 
methods, namely the Loopamp PURE DNA Extraction Kit, InstaGene Matrix, and 
boiling. Thirteen of 14 clinical samples and 34 of 34 samples spiked with S. 
zooepidemicus at concentrations greater than 1×104 CFU/ml were positive by Sz-LAMP 
plus the Loopamp PURE DNA Extraction Kit; 11 of these 14 clinical samples and 31 of 
34 spiked samples were positive with LAMP plus InstaGene Matrix, and 7 and 27 were 
positive with LAMP plus boiling. The inhibitors remaining after DNA extraction using 
InstaGene Matrix or boiling might have inhibited the LAMP reaction; the Loopamp 
PURE DNA Extraction Kit would have been more likely than the other extraction 
methods to reduce the effect of these inhibitors, indicating that this kit was the most 
suitable DNA extraction method for use on clinical samples from the equine respiratory 
tract. The use of seven LAMP methods the five new developed ones and two 
previously described ones targeting E. coli and P. aeruginosa in combination with the 
Loopamp PURE DNA Extraction Kit obtained high accordance rates with bacterial 
culture: 91.0% to 100% (using a threshold of 1×104 CFU/ml) and 85.1% to 100% (using 
20 CFU/ml). These high accordance rates indicated that LAMP assays could be useful 
tools for detecting the bacterial pathogens causing lower respiratory tract infection in 
horses. 
 In CHAPTER 3, the author revealed the antimicrobial susceptibility patterns of 
those pathogenic bacteria for which the LAMP detection methods in CHAPTER 2 had 
been developed. Beta-lactams such as penicillin and cephalothin are useful as first-line 
drugs for bacterial infection of the adult equine lower respiratory tract because the 
dominant causative bacterium, S. zooepidemicus, was consistently susceptible to these 
agents in this study. The percentage of minocycline-resistant S. zooepidemicus and E. 
coli isolates increased between 2010 and 2014. The dominant causative obligate 
anaerobes, Bacteroides and Prevotella, were all susceptible to metronidazole, although 
metronidazole-resistant Bacteroides and Prevotella strains have recently been reported 
in humans. This result suggests that metronidazole may still be useful against obligate 
anaerobes in horses. The information revealed here on antimicrobial susceptibility 
patterns could be very useful for Japanese veterinarians to select appropriate 
antimicrobials for horses with bacterial infections of the lower respiratory tract. 
 Using the LAMP methods plus the Loopamp PURE DNA Extraction Kit will 
enable veterinary practitioners to detect seven dominant bacterial pathogen groups in 
the lower respiratory tract of adult horses. These methods can be applied in the clinic 
with the naked eye and take no more than 90 min. Veterinary practitioners can select 
appropriate antimicrobials as the initial step in treatment through the quick 
identification of causative bacteria and antimicrobial susceptibility patterns. These swift 
and appropriate therapies will improve therapeutic efficacy in adult horses with lower 
respiratory bacterial infection. 
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